These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 587708)

  • 1. Laboratory studies on mecillinam: activity alone and combined with cephradine.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():53-8. PubMed ID: 587708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
    Chattopadhyay B; Hall I
    J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
    Sakamoto M; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to beta-lactam antibiotics Proteus strains.
    Lachmajer-Lutoslawska M; Bobrowski M
    Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Lactamases and resistance to penicillins and cephalosporins in Serratia marcescens.
    Farrar WE; O'dell NM
    J Infect Dis; 1976 Sep; 134(3):245-51. PubMed ID: 789784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.
    Neu HC
    Antimicrob Agents Chemother; 1976 May; 9(5):793-9. PubMed ID: 949176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ; Washington JA
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concept of class in relation to first-generation cephalosporins].
    De Toffoli A; Fantin B; Vechiet D
    Quad Sclavo Diagn; 1984 Jun; 20(2):181-6. PubMed ID: 6441962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational choice of penicillins and cephalosporins based on parallel in-vitro and in-vivo tests.
    Selwyn S
    Lancet; 1976 Sep; 2(7986):616-9. PubMed ID: 61353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.
    Baltimore RS; Klein JO; Wilcox C; Finland M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):701-5. PubMed ID: 1267442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.
    Neu HC
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():43-52. PubMed ID: 893247
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of penicillinases produced by R factors isolated from ampicillin-resistant gram-negative bacteria.
    Ooka T; Hashimoto H; Mitsuhashi S
    Jpn J Microbiol; 1970 Mar; 14(2):123-8. PubMed ID: 4910534
    [No Abstract]   [Full Text] [Related]  

  • 16. Diversity of beta-lactamase activity among clinical isolates of gram-negative bacilli.
    Farrar WE; Newsome JK
    Am J Clin Pathol; 1976 Apr; 65(4):570-4. PubMed ID: 817594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A laboratory evaluation of a novel (beta-lactam antibiotic mecillinam.
    Reeves DS; Wise R; Bywater MJ
    J Antimicrob Chemother; 1975 Sep; 1(3):337-44. PubMed ID: 241740
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmentin: laboratory studies.
    Farrell ID; Turner PJ
    Scott Med J; 1982; 27 Spec No.():S21-3. PubMed ID: 6762661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and beta-lactamase stability of cefazaflur compared with those of beta-lactamase-stable cephalosporins.
    Aswapokee N; Neu HC
    Antimicrob Agents Chemother; 1979 Mar; 15(3):444-6. PubMed ID: 313753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.